Impact of Prospective Quarterly Audits on Pharmaceutical Costs in a 32-bed Mixed Adult ICU

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: author
License: Not specified
Serval ID
serval:BIB_1721DA190094
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Title
Impact of Prospective Quarterly Audits on Pharmaceutical Costs in a 32-bed Mixed Adult ICU
Title of the conference
Schweiz Med Forum
Author(s)
Eggimann P, Voirol P., Chioléro R., Gattlen L., Mariotti G., Wasserfallen J. B., Jolliet P.
Publisher
EMH
Organization
Société Suisse de Médecine Intensive
Publication state
Published
Issued date
09/2010
Volume
10
Pages
23S
Language
english
Abstract
Five-year increase in quantities and costs of drug prescription in an ICU is a matter of concern. However, confounding factors such as general activity and inflation should be taken into account. Furthermore, our data suggest that implementation of interdisciplinary quarterly internal audits with feedback to prescribers may have
contributed to controlling drug-related costs in our adult mixed ICU.
Keywords
Critical care, pharmacoeconoma, audits
Create date
09/03/2011 9:28
Last modification date
17/07/2020 6:26
Usage data